These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3749230)

  • 1. Verapamil does not antagonize LSD-induced stimulus control.
    Winter JC
    Pharmacol Biochem Behav; 1986 Jul; 25(1):227-8. PubMed ID: 3749230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulus effects of ibogaine in rats trained with yohimbine, DOM, or LSD.
    Palumbo PA; Winter JC
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1221-6. PubMed ID: 1475306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of 5-methoxy-N,N-dimethyltryptamine and dose-dependent antagonism by BC-105.
    Young R; Rosecrans JA; Glennon RA
    Psychopharmacology (Berl); 1983; 80(2):156-60. PubMed ID: 6410445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus properties of pizotifen maleate (BC105): a putative serotonin antagonist.
    Minnema DJ; Hendry JS; Rosecrans JA
    Psychopharmacology (Berl); 1984; 83(2):200-4. PubMed ID: 6431474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stimulus properties of para-methoxyamphetamine: a nonessential serotonergic component.
    Winter JC
    Pharmacol Biochem Behav; 1984 Feb; 20(2):201-3. PubMed ID: 6546992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative discriminative stimulus effects of 5-methoxy-N,N-dimethyltryptamine and LSD.
    Young R; Rosecrans JA; Glennon RA
    Life Sci; 1982 Jun; 30(24):2057-62. PubMed ID: 7109835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus.
    Winter JC; Rabin RA
    Pharmacol Biochem Behav; 1988 Jul; 30(3):617-24. PubMed ID: 3211970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
    Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced stimulus control and the concept of breaking point: LSD and quipazine.
    Winter JC
    Psychopharmacology (Berl); 1981; 72(2):217-8. PubMed ID: 6782615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behaviorally inactive doses of mianserin antagonize the suppressant effect of lysergic acid diethylamide on a fixed-ratio operant.
    Dwoskin LP; Sparber SB
    J Pharmacol Exp Ther; 1983 Apr; 225(1):77-84. PubMed ID: 6834279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pizotifen (BC-105) attenuates orienting and Pavlovian heart rate conditioning in rabbits.
    Ginn SR; Powell DA
    Pharmacol Biochem Behav; 1986 Mar; 24(3):677-85. PubMed ID: 3703901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of the LSD cue by putative serotonin antagonists: relationship to inhibition of in vivo [3H]spiroperidol binding.
    Nielsen EB; Ginn SR; Cunningham KA; Appel JB
    Behav Brain Res; 1985 Aug; 16(2-3):171-6. PubMed ID: 2931089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide.
    Gresch PJ; Barrett RJ; Sanders-Bush E; Smith RL
    J Pharmacol Exp Ther; 2007 Feb; 320(2):662-9. PubMed ID: 17077317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A characterization of LSD-antagonist effects of pirenperone in the rat.
    Colpaert FC; Janssen PA
    Neuropharmacology; 1983 Aug; 22(8):1001-5. PubMed ID: 6621823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The time-dependent stimulus effects of R(-)-2,5-dimethoxy-4-methamphetamine (DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents.
    Fiorella D; Palumbo PA; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 May; 119(2):239-45. PubMed ID: 7659772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.
    Mokler DJ; Commissaris RL; Warner MR; Rech RH
    J Pharmacol Exp Ther; 1983 Dec; 227(3):557-62. PubMed ID: 6655557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli.
    Winter JC; Eckler JR; Rabin RA
    Psychopharmacology (Berl); 2004 Mar; 172(2):233-40. PubMed ID: 14598016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminative stimulus properties of lysergic acid diethylamide in the monkey.
    Nielsen EB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):244-9. PubMed ID: 4009503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yohimbine-induced stimulus control in the rat.
    Winter JC
    Arch Int Pharmacodyn Ther; 1978 Sep; 235(1):86-92. PubMed ID: 736694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of N,N-dimethyltryptamine, harmaline, and selected congeners in rats trained with LSD as a discriminative stimulus.
    Helsley S; Fiorella D; Rabin RA; Winter JC
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):649-63. PubMed ID: 9682278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.